COMPETITION OF ADENINE NUCLEOTIDES FOR A l,3‐[3H]‐DIPROPYL‐8‐CYCLOPENTYLXANTHINE BINDING SITE IN RAT VAS DEFERENS
- 1 July 1997
- journal article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 24 (7) , 492-497
- https://doi.org/10.1111/j.1440-1681.1997.tb01233.x
Abstract
SUMMARY: 1. The binding of l,3‐[3H]‐dipropyl‐8‐cyclopentylxanthine ([3H]‐DPCPX), a specific adenosine Ai receptor antagonist, was examined in rat vas deferens membrane preparations using radioligand binding techniques.2. l,3‐[3H]‐Dipropyl‐8‐cyclopentylxanthine bound to these preparations with a KD of 1.07 ± 0.14 nmol/L (n = 6). The density of [3H]‐DPCPX binding sites was 133.38 ± 5.57 fmol/mg protein.3. Computer analysis indicated that nucleosides competed for [3H]‐DPCPX binding at two distinct sites. The rank order of potency at the higher affinity site corresponded to R‐phenyliso‐propyladenosine (R‐PIA) 2‐chloroadenosine (2‐CI ADO) cyclopentyladenosine (CPA) N‐ethylcarboxamidoadenosine (NECA)>s‐phenylisopropyladenosine (s‐PIA). Kj values were in the low nmol/L range. The rank order of nucleoside potency at the lower affinity site corresponded to R‐PIA CPA NECA>=2‐ClADO> S‐PIA. Ki values were in the low μmol/L range.4. Nucleotides competed for [3H]‐DPCPX binding at a single site only. The rank order of potency at this site corresponded to a,β‐methylene ATP βγ‐methylene ATP = ATP. Ki values were in the high |xmol/L range. This site seemed to correspond with one of the two binding sites predicted by nucleoside competition binding.5. The ATP‐regenerating compound myokinase did not significantly change the competition curve for ATP, indicating that the competition for [3H]‐DPCPX binding observed in the presence of ATP was due to an effect of ATP per se and not to an action of a degradation product.6. The results demonstrate that in rat vasa deferentia there exist two distinct binding sites for [3H]‐DPCPX. One of these sites binds only nucleosides and may represent an adenosine Ai receptor, as usually defined. The other site binds both nucleosides and nucleotides and may represent an atypical adenosine A1 receptor, an atypical P2 or a P3 purinoceptor.Keywords
This publication has 18 references indexed in Scilit:
- Pharmacological analysis of ecto‐ATPase inhibition: evidence for combined enzyme inhibition and receptor antagonism in P2X‐purinoceptor ligandsBritish Journal of Pharmacology, 1994
- The binding of 1,3‐[3H]‐dipropyl‐8‐cyclopentylxanthine to adenosine Ai receptors in rat smooth muscle preparationsBritish Journal of Pharmacology, 1994
- 1,3-Dipropyl-8-cyclopentyl xanthine (DPCPX): A Useful Tool for Pharmacologists and Physiologists?General Pharmacology: The Vascular System, 1994
- Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1- and P2-purinoceptorsBritish Journal of Pharmacology, 1993
- Participation by purines in the modulation of norepinephrine release by methoxamineEuropean Journal of Pharmacology, 1991
- Characterization of prejunctional purinoceptors on adrenergic nerves of the rat caudal arteryNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1988
- Purinergic Neurotransmission and NeuromodulationAnnual Review of Pharmacology and Toxicology, 1983
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingAnalytical Biochemistry, 1976
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949